What was schizophrenia originally called

What was schizophrenia originally called DEFAULT

The term “schizophrenia” was coined by Eugen Bleuler.

The history of schizophrenia is complex and does not lend itself easily to a linear narrative. Accounts of a schizophrenia-like syndrome are rare in records before the 19th century. The earliest cases detailed were reported in 1797, and 1809.Dementia praecox, meaning premature dementia ( brain dementia odf the young) was used by German psychiatrist Heinrich Schüle in 1886, and then in 1891 by Arnold Pick in a case report of hebephrenia (Disorganized schizophrenia, or hebephrenia, is a subtype of schizophrenia)  In 1893 Emil Kraepelin used the term in making a distinction, known as the Kraepelinian dichotomy, between the two psychoses – dementia praecox, and manic depression (now called bipolar disorder). Kraepelin believed that dementia praecox was probably caused by a systemic disease that affected many organs and nerves, affecting the brain after puberty in a final decisive cascade. It was thought to be an early form of dementia, a degenerative disease. When it became evident that the disorder was not degenerative it was renamed schizophrenia by Eugen Bleuler in 1908.

The word schizophrenia translates roughly as “splitting of the mind” and is Modern Latin from the Greek roots schizein (σχίζειν, “to split”) and phrēn, (φρεν, “mind”) Its use was intended to describe the separation of function between personality, thinking, memory, and perception. Bleuler described four primary symptoms of schizophrenia. According to him, the ‘4A’s’ of schizophrenia were – Ambivalence, Autism, reduced Association (or disassociation) of ideas and flat Affect. In addition to this, Bleuler also observed that this disorder was different from dementia praecox, as some individuals recovered partially instead of progressively worsening.

The term schizophrenia used to be associated with split personality by the general population but that usage went into decline when split personality became known as a separate disorder, first as multiple identity disorder , and later as dissociative identity disorder. In 2002 in Japan the name was changed to integration disorder, and in 2012 in South Korea, the name was changed to attunement disorder to reduce the stigma, both with good results.


Scratch-drawings on the wall in St. Elizabeths Hospital made by a prisoner with “a disturbed case of dementia praecox”.

In the early 20th century, the psychiatrist Kurt Schneider listed the psychotic symptoms of schizophrenia into two groups of hallucinations, and delusions. The hallucinations were listed as specific to auditory, and the delusional included thought disorders. These were seen as the symptoms of first-rank importance and were termed first-ranksymptoms (FRS). Whilst these were also sometimes seen to be relevant to the psychosis in manic-depression, they were highly suggestive of schizophrenia and typically referred to as first-rank symptoms of schizophrenia.  Schneider formulated this list of first-rank symptoms in order to classify and separate schizophrenia from other psychotic disorders. The major first-rank symptoms include – hallucinations (auditory and somatic), thought insertion, thought broadcasting and delusional perception. The most common first-rank symptom was found to belong to thought disorders.Schneider’s first-rank symptoms have been instrumental in designing the diagnostic criteria for schizophrenia, however, the exact nature of these symptoms is not very thorough and they have been questioned. In 2013 the first-rank symptoms were excluded from the DSM-5 criteria. First-rank symptoms are seen to be of limited use in detecting schizophrenia but may be of help in differential diagnosis.

A molecule of chlorpromazine, the first antipsychotic developed in the 1950s.

The earliest attempts to treat schizophrenia were psychosurgical, involving either the removal of brain tissue from different regions or the severing of pathways. These were notably frontal lobotomies and cingulotomies which were carried out from the 1930s. In the 1930s a number of shock therapies were introduced which induced seizures (convulsions) or comas. Insulin shock therapy involved the injecting of large doses of insulin in order to induce comas, which in turn produced hypoglycemia and convulsions. The use of electricity to induce seizures was developed, and in use as electroconvulsivetherapy(ECT)by 1938. Stereotactic surgeries were developed in the 1940s. Treatment was revolutionized in the mid-1950s with the development and introduction of the first typicalantipsychoticchlorpromazine. In the 1970s the first atypical antipsychoticclozapine, was introduced followed by the introduction of others.

In the early 1970s in the US, the diagnostic model used for schizophrenia was broad and clinically-based using DSM II. It had been noted that schizophrenia was diagnosed far more in the US than in Europe which had been using the ICD-9 criteria. The US model was criticized for failing to demarcate clearly those people with a mental illness, and those without. In 1980 DSM III was published and showed a shift in focus from the clinically-based biopsychosocial model to a reason-based medical model. DSM IV showed an increased focus to an evidence-based medical model. DSM-5 was published in 2013 and introduced changes to DSM IV.

After an evolving through six editions of the Diagnostic and Statistical Manual of Mental Disorders (DSM), the exact definition of schizophrenia still remains elusive. Initially, diagnosing schizophrenia was focused on the Kraepelinian concepts of the disorders poor outcome, chronicity and patients avolition. A broader definition of the disorder was reflected in DSM – I and DSM – II. These two editions used Bleuler’s symptoms as a reference and focused mainly on the interpersonal pathology and negative symptoms. The DSM – III and subsequently the DSM – III R and DSM – IV, adopted Kurt Schneider’s first-rank symptoms and highlighted them in addition to the chronic nature and lack of functioning seen in the disorder. The primary construct of the DSM – IV was seen to be reliable, had a fair amount of validity, but more importantly, was clinically relevant. Therefore the primary definition of schizophrenia remains unchanged in the DSM – 5.

However, it is to be noted here that the heterogeneity of the disorder is inadequately described by the various subtypes of schizophrenia listed in the DSM – IV. In addition to this, the diagnostic effectiveness of Schneider’s first-rank symptoms have been scrutinized even more, as its focus on special hallucinations and bizarre delusions further obscure the diagnosis of schizophrenia. According to the DSM – 5, the five characteristic symptoms of schizophrenia of which, at least two are to be present for a period of one month, will remain unchanged. These include – hallucinations, delusions, disorganized speech, catatonic behavior and negative symptoms.

Prior to the elimination of its subtypes, schizophrenia had the following distinct clinical subtypes – paranoid, undifferentiated, disorganized and catatonic, with the paranoid subtype being the most commonly diagnosed among patients. However, studies have shown that these subtypes are not reliable, are not stable over a period of time and have little or no prognostic value. In addition, these subtypes do not tend to occur together in families and many a time, patients present with more than one subtype. Finally, the subtypes mentioned above do not respond to any particular pattern of treatment and they cannot be inherited from parent to offspring. As a result, these subtypes of schizophrenia have now been eliminated. The DSM – 5 focuses on the psychopathological aspects of the disorder in order to more effectively address its heterogeneity which can have a higher validity, better use clinically and encourage measurement-based treatment. Along with these new approaches and with the help of the DSM – 5 in combining the neurobiological and genetic aspects of schizophrenia, it might be possible to unravel the true nature behind this mysterious disorder.

It is important to note that Anti-psychiatrists agree that ‘schizophrenia’ represents a problem, and that many human beings have problems living in modern society. But they protest the notion that schizophrenia is a disease, and that people who suffer from it are sick. Instead, they often suggest that schizophrenics appear crazy because they are intelligent and sensitive beings confronted with a mad world. The sane patient can choose to go Against medical advice, but the insane usually can not. Anti-psychiatry often describes the institutional world as itself pathological and insane because of the way it subordinates human beings to bureaucracy, protocol, and labels.

David Rosenhan’s 1972 study, published in the journal Science under the title On being sane in insane places, concluded that the diagnosis of schizophrenia in the US was often subjective and unreliable.

In 2017, the Global Burden of Disease Study estimated there were 1.1 million new cases, and in 2019 WHO reported a total of 20 million cases globally. Schizophrenia affects around 0.3–0.7% of people at some point in their life.  About 1.1% of adults have schizophrenia in the United States. It occurs 1.4 times more frequently in males than females and typically appears earlier in men – Although schizophrenia can occur at any age, the average age of onset tends to be in the late teens to the early 20s for men, and the late 20s to early 30s for women. Onset in childhood, before the age of 12 can sometimes occur, however this is uncommon. A later onset can occur between the ages of 40 and 60, known as late onset, and also after 60 known as very late onset (also uncommon).

Schizophrenia has great human and economic costs. It results in a decreased life expectancy of 20 years. This is primarily because of its association with obesity, poor diet, a sedentary lifestyle, and smoking, with an increased rate of suicide playing a lesser role. Side effects of antipsychotics may also increase the risk. These differences in life expectancy increased between the 1970s and 1990s. An Australian study puts the rate of early death at 25 years, and views the main cause to be related to heart disease.

Key Takeaways

First-ranksymptoms (FRS)

The symptoms of first-rank importance that are truly defining, or key, in the diagnosis of schizophrenia.


Sours: https://courses.lumenlearning.com/hvcc-abnormalpsychology/chapter/history-of-schizophrenia/

The Name “Schizophrenia” Is Heard Worldwide

However, the schizophrenia that Bleuler described was not free of problems. The secondary symptoms were difficult to define, open to misinterpretation, and fostered a purely psychological view of the condition.

Bleuler saw schizophrenia as an extension of normal personality that could, with perseverance, be understood and ultimately provide an insight into human nature. His classification was optimistic and gradualist, maintaining the option that it was ultimately a manifestation of the human condition.

Schizophrenia endures and will remain-in one form or another-as the ürword for psychiatry. To quote Tim Crow, “Schizophrenia is not just an illness of humans, it may be THE illness of humanity.”3 A century later, Bleuler would have good reason to be pleased with his creation.


Dr Kaplanis Clinical Associate Professor at the Graduate School of Medicine, Wollongong University and Research Fellow, History Department, Stellenbosch University. He wrote about Eugen Bleuler in his bookThe Exceptional Brain and How it Changed the World (2011).


1. Kaplan RM. Being Bleuler: the second century of schizophrenia. Australas Psychiatry. 2008;16(5):305-311.

2. Bleuler E. (1950). Dementia praecox or the group of schizophrenias. International Universities Press.

3. Crow TJ. ‘Is schizophrenia the price that Homo sapiens pay for language?’Schizophr Res. 1997; 28:127-141.

Sours: https://www.psychiatrictimes.com/view/name-schizophrenia-heard-worldwide
  1. Paramount plus.com/vizio
  2. Heart eye emoji coloring page
  3. Harbor pines homes for sale
  4. Gearwrench mechanics tool set
  5. Multi domain task force army

The word "schizophrenia" is less than 100 years old. However the disease was first identified as a discrete mental illness by Dr. Emile Kraepelin in the 1887 and the illness itself is generally believed to have accompanied mankind through its history.

Written documents that identify Schizophrenia can be traced to the old Pharaonic Egypt, as far back as the second millennium before Christ. Depression, dementia, as well as thought disturbances that are typical in schizophrenia are described in detail in the Book of Hearts. The Heart and the mind seem to have been synonymous in ancient Egypt. The physical illnesses were regarded as symptoms of the heart and the uterus and originating from the blood vessels or from purulence, fecal matter, a poison or demons.

A recent study into the ancient Greek and Roman literature showed that although the general population probably had an awareness of psychotic disorders, there was no condition that would meet the modern diagnostic criteria for schizophrenia in these societies.

At one point, all people who were considered "abnormal," whether due to mental illness, mental retardation, or physical deformities, were largely treated the same. Early theories supposed that mental disorders were caused by evil possession of the body, and the appropriate treatment was then exorcising these demons, through various means, ranging from innocuous treatments, such as exposing the patient to certain types of music, to dangerous and sometimes deadly means, such as releasing the evil spirits by drilling holes in the patient's skull.

One of the first to classify the mental disorders into different categories was the German physician, Emile Kraepelin. Dr. Kraepelin used the term "dementia praecox" for individuals who had symptoms that we now associate with schizophrenia.

The nonspecific concept of madness has been around for many thousands of years and schizophrenia was only classified as a distinct mental disorder by Kraepelin in 1887. He was the first to make a distinction in the psychotic disorders between what he called dementia praecox and manic depression. Kraepelin believed that dementia praecox was primarily a disease of the brain, and particularly a form of dementia. Kraepelin named the disorder 'dementia praecox' (early dementia) to distinguish it from other forms of dementia (such as Alzheimer's disease) which typically occur late in life. He used this term because his studies focused on young adults with dementia.

The Swiss psychiatrist, Eugen Bleuler, coined the term, "schizophrenia" in 1911. He was also the first to describe the symptoms as "positive" or "negative." Bleuler changed the name to schizophrenia as it was obvious that Krapelin's name was misleading as the illness was not a dementia (it did not always lead to mental deterioration) and could sometimes occur late as well as early in life.

The word "schizophrenia" comes from the Greek roots schizo (split) and phrene (mind) to describe the fragmented thinking of people with the disorder. His term was not meant to convey the idea of split or multiple personality, a common misunderstanding by the public at large. Since Bleuler's time, the definition of schizophrenia has continued to change, as scientists attempt to more accurately delineate the different types of mental diseases. Without knowing the exact causes of these diseases, scientists can only base their classifications on the observation that some symptoms tend to occur together.

Both Bleuler and Kraepelin subdivided schizophrenia into categories, based on prominent symptoms and prognoses. Over the years, those working in this field have continued to attempt to classify types of schizophrenia. Five types were delineated in the DSM-III: disorganized, catatonic, paranoid, residual, and undifferentiated. The first three categories were originally proposed by Kraepelin.

These classifications, while still employed in DSM-IV, have not shown to be helpful in predicting outcome of the disorder, and the types are not reliably diagnosed. Many researchers are using other systems to classify types of the disorder, based on the preponderance of "positive" vs "negative" symptoms, the progression of the disorder in terms of type and severity of symptoms over time, and the co-occurrence of other mental disorders and syndromes. It is hoped that differentiating types of schizophrenia based on clinical symptoms will help to determine different etiologies or causes of the disorder.

The evidence that schizophrenia is a biologically-based disease of the brain has accumulated rapidly during the past two decades. Recently this evidence has been also been supported with dynamic brain imaging systems that show very precisely the wave of tissue distruction that takes place in the brain that is suffering from schizophrenia.

With the rapid advances in the genetics of human desease now taking place, the future looks bright that greatly more effective therapies and eventually cures - will be identified.

More "History of Schizophrenia" information

More In-Depth History on Schizophrenia
(Source: Karolinska Institute, Department of Clinical Neuroscience)

Schizophrenia during the Middle Ages in the Muslim World

Psychiatry during the middle ages in the Western countries- an overview

Psychiatry during the early 20th century - A European Example

The Old Asylums



Sours: http://schizophrenia.com/history.htm
The 3 Traits of Psychosis [\u0026 What They Feel Like]

[Article revised on 4 May 2020.]


Source: Pixabay

What does ‘schizophrenia’ mean?

In 1910, the Swiss psychiatrist Paul Eugen Bleuler (d. 1939) coined the term 'schizophrenia’ from the Greek words schizo (‘split’) and phren (‘mind’). Bleuler had intended the term to denote a ‘loosening’ of thoughts and feelings, but, unfortunately, many people read it (and still read it) to mean a ‘split personality’.

What does ‘schizophrenia’ not mean?

Robert Louis Stevenson’s novel The Strange Case of Dr Jekyll and Mr Hyde (1886) did much to popularize the concept of a ‘split personality’, which is sometimes also referred to as ‘multiple personality disorder’ (MPD). However, MPD is a vanishingly rare condition that is entirely unrelated to schizophrenia. The vast majority of psychiatrists, myself included, have never seen a case of MPD, and many if not most suspect that such a condition does not exist. Yes, schizophrenia sufferers may hear various voices, or harbour strange beliefs, but this is not the same as having a ‘split personality’. Unlike Dr Jekyll, schizophrenia sufferers do not suddenly mutate into a different, unrecognizable person.

Ironically, Bleuler had intended to clarify matters by replacing the older, even more misleading term of dementia præcox [‘dementia of early life’]. This older term had been championed by the eminent German psychiatrist Emil Kraepelin (d. 1926), who believed, wrongly, that the illness only struck young people, and inevitably led to mental deterioration. Bleuler disagreed on both counts, and, therefore, renamed the illness ‘schizophrenia’. He held that, instead of mental deterioration, schizophrenia led to a sharpening of the senses and heightened consciousness of memories and experiences.

It is as common as it is unfortunate to hear the adjective ‘schizophrenic’ bandied about to mean something like ‘changeable’, ‘volatile’, or ‘unpredictable’, as in, ‘The weather today has been very schizophrenic.’ This sort of usage ought to be discouraged insofar as it perpetuates people’s misunderstanding of the illness, and, by extension, the stigmatization of schizophrenia sufferers. Even used correctly, the term ‘schizophrenic’ labels a person by an illness, implicitly reducing him or her to that illness. But people aren’t ‘schizophrenics’ any more than they are ‘diabetics’ or suffering with toothache.

Who ‘discovered’ schizophrenia?

Despite his shortcomings, Kraepelin was the first to distinguish schizophrenia from other forms of psychosis, and in particular from the ‘affective psychoses’ that can supervene in mood disorders such as depression and bipolar disorder. His classification of mental disorders, the Compendium der Psychiatrie, is the forerunner of today’s most influential classifications of mental disorders, the Diagnostic and Statistical Manual of Mental Disorders 5th Revision (DSM-5) and the International Classification of Diseases 11th Revision (ICD-11). As well as listing mental disorders, these classifications provide operational definitions and diagnostic criteria that physicians and researchers use to establish and verify diagnoses.

Kraepelin first carved out schizophrenia from other forms of psychosis in 1887, but that is not to say that schizophrenia— or dementia præcox, as he called it—had not existed long before his day. The oldest available description of an illness closely resembling schizophrenia can be found in the Ebers papyrus, which dates back to the Egypt of 1550 BCE. And archæological finds of Stone Age skulls with burr holes—drilled, presumably, to release evil spirits—have led to speculation that schizophrenia is as old as humankind.

How was schizophrenia thought of in antiquity?

In antiquity, people did not think of ‘madness’ (a term that they used indiscriminately for all forms of psychosis) in terms of mental disorder, but in terms of divine punishment or demonic possession. Evidence for this comes from the Old Testament, and most notably from the First Book of Samuel, according to which King Saul became ‘mad’ after neglecting his religious duties and angering God. The fact that David used to play on his harp to make Saul better suggests that, even in antiquity, people believed that psychotic illnesses could be successfully treated.

But the spirit of the Lord departed from Saul, and an evil spirit from the Lord troubled him … And it came to pass, when the evil spirit from God was upon Saul, that David took an harp, and played with his hand: so Saul was refreshed, and was well, and the evil spirit departed from him.

When did people first start thinking of schizophrenia as an illness?

In Greek mythology and the Homerian epics, madness is similarly thought of as a punishment from God—or the gods—and it is in actual fact not until the time of the Greek physician Hippocrates (d. 377 BCE) that mental illness first became an object of scientific speculation.

Hippocrates taught that madness resulted from an imbalance of four bodily humours, and that it could be cured by rebalancing these humours with such treatments as special diets, purgatives, and blood-lettings. To modern readers, Hippocrates’ ideas may seem far-fetched, perhaps even on the dangerous side of eccentric, but in the 4th century BCE they represented a significant advance on the idea of mental disorder as a punishment from God.

Only from the brain springs our pleasures, our feelings of happiness, laughter and jokes, our pain, our sorrows and tears … This same organ makes us mad or confused, inspires us with fear and anxiety…

The Greek philosopher Aristotle (d. 322 BCE) and later the Roman physician Galen (d. 216 CE) expanded on Hippocrates’ humoural theories, and both men played an important role in establishing them as Europe’s dominant medical model.

In Ancient Rome, the physician Asclepiades (d. 40 BCE) and the statesman and philosopher Cicero (d. 43 BCE) rejected Hippocrates’ humoural theories, asserting, for example, that melancholia (depression) resulted not from an excess of ‘black bile’ but from emotions such as rage, fear, and grief. Unfortunately, in the 1st century CE the influence of these luminaries began to decline, and the influential Roman physician Celsus (d. 50 CE) reinstated the idea of madness as a punishment from the gods—an idea which gained currency with the rise of Christianity and the fall of the Roman Empire.

In the Middle Ages, religion became central to cure and, alongside the mediæval asylums such as the Bethlehem (an infamous asylum in London that is at the origin of the expression, ‘like a bad day at Bedlam’), some monasteries transformed themselves into centres for the treatment of mental disorder. This is not to say that the humoural theories of Hippocrates had been supplanted, but merely that they had been incorporated into the prevailing Christian dogma, and the purgatives and blood-lettings continued alongside the prayers and confession.

How did beliefs change?

The burning of the so-called heretics—often people suffering from psychotic illnesses such as schizophrenia—began in the early Renaissance and reached its peak in the 14th and 15th centuries. First published in 1563, De præstigiis dæmonum [The Deception of Demons] argued that the madness of ‘heretics’ resulted not from divine punishment or demonic possession, but from natural causes. The Church proscribed the book and accused its author, Johann Weyer, of being a sorcerer.

From the 15th century, scientific breakthroughs such as the anatomy of Vesalius (d. 1564) and the heliocentric system of Galileo (d. 1642) began challenging the authority of the Church, and the centre of attention and study gradually shifted from God to man and from the heavens to the Earth. Even so, the humoural theories of Hippocrates perdured into the 17th and 18th centuries, to be mocked by the playwright Molière (d. 1673) in such works as Le Malade imaginaire [The Imaginary Invalid] and Le Médecin malgré lui [The Doctor in Spite of Himself].

Empirical thinkers such as John Locke (d. 1704) in England and Denis Diderot (d. 1784) in France challenged this status quo by arguing, very much as Cicero had done, that reason and emotions are caused by nothing more or less than sensations. Also in France, the physician Philippe Pinel (d. 1826) began regarding mental disorder as the result of exposure to psychological and social stressors, and, to a lesser extent, of heredity and physiological damage. A landmark in the history of psychiatry, Pinel’s Traité Médico -philosophique sur l’aliénation mentale ou la manie [A Treatise on Insanity] called for a more humane approach to the treatment of mental disorder. This ‘moral treatment’ included respect for the person, a trusting and confiding doctor-patient relationship, decreased stimuli, routine activity, and the abandonment of old-fashioned Hippocratic treatments. At about the same time as Pinel in France, the Tukes (father and son) in England founded the York Retreat, the first institution ‘for the humane care of the insane’ in the British Isles.

How did beliefs evolve in the 20th century?

Sigmund Freud (d. 1939) and his disciples influenced much of 20th century psychiatry, and by the second half of the century a majority of psychiatrists in the US (although not in the UK) had come to believe that mental disorders such as schizophrenia resulted from unconscious conflicts originating in early childhood.

In the latter part of the 20th century, neuroimaging techniques, genetic studies, and pharmacological breakthroughs such as the first antipsychotic drug chlorpromazine completely reversed this psychoanalytical model of mental disorder, and prompted a return to a more biological, ‘neo-Kraepelinian’ model. At present, schizophrenia is primarily seen as a biological disorder of the brain, although it is also acknowledged that psychological and social stressors can play an important part in triggering episodes of illness, and that different approaches to treatment should be seen not as competing but as complementary.

Even so, critics tend to deride this ‘bio-psycho-social’ model as little more than a ‘bio-bio-bio’ model, with psychiatrists reduced to mere diagnosticians and pill pushers. Many critics question the scientific evidence underpinning such a robust biological approach, and call for a radical rethink of mental disorders, not as detached disease processes that can be cut up into diagnostic labels, but as subjective and meaningful experiences grounded in both personal and larger sociocultural narratives.

What treatments were used before the advent of antipsychotic medication?

Febrile illnesses such as malaria had been observed to temper psychotic symptoms, and in the early 20th century, ‘fever therapy’ became a common form of treatment for schizophrenia. Psychiatrists attempted to induce fevers in their patients, sometimes by means of injections of sulphur or oil. Other popular treatments included sleep therapy, gas therapy, electroconvulsive (electroshock) therapy, and prefrontal leucotomy (lobotomy), which involved severing the part of the brain that processes emotions. Sadly, many such ‘treatments’ aimed more at controlling disturbed behaviour than at curing illness or alleviating suffering. In some countries, such as Germany during the Nazi era, the conviction that schizophrenia resulted from a ‘hereditary defect’ led to atrocious acts of forced sterilization and genocide. The first antipsychotic drug, chlorpromazine, first became available in the 1950s. Although far from perfect, it opened up an era of hope and promise for people with schizophrenia.

So, where to now?

In 1919, Kraepelin stated that ‘the causes of dementia præcox are at the present time still mapped in impenetrable darkness’. Since then, greater understanding of the causes of schizophrenia has opened up multiple avenues for the prevention and treatment of the illness, and a broad range of pharmacological, psychological, and social interventions have been scientifically proven to work.

Today, schizophrenia sufferers stand a better chance than at any other time in history of leading a normal life. And thanks to the fast pace of ongoing medical research, a good outcome is increasingly likely.

Neel Burton is author of The Meaning of Madnessand other books.

Sours: https://www.psychologytoday.com/us/blog/hide-and-seek/201209/brief-history-schizophrenia

Was schizophrenia called what originally

The diagnostic concept of schizophrenia: its history, evolution, and future prospects

1. Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures. Psychol Med.1992 (monograph suppl 20):1–97. [PubMed] [Google Scholar]

2. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry. 2006;11:815–836. [PubMed] [Google Scholar]

3. Morel BA. Traité des maladies mentales. [Treatise on mental diseases]. Paris, France: Masson; 1860.[Google Scholar]

4. Clouston TS. Clinical Lectures on Mental Diseases.6th ed London, UK: J&A Churchill; 1904.[Google Scholar]

5. Kahlbaum KL. Die Gruppierung der psychischen Krankheiten und die Einteilung der Seelenstörungen.[The Grouping of Psychiatric Diseases and the Classification of Mental Disturbances]. Danzig, Germany: Kafemann; 1863.[Google Scholar]

6. Hecker E. Die Hebephrenie: ein Beitrag zur klinischen Psychiatrie. [Hebephrenia: a contribution to clinical psychiatry] Archiv für pathologische Anatomie und für klinische Medizin. 1871;52:394–429.[Google Scholar]

7. Kraepelin E. Psychiatrie. 6 Auflage. Leipzig, Austria: Barth 1899. English translation by Metoui H, Ayed S: Psychiatry, A Textbook for Students and Physicians, Canton, MA: Science History Publications. Ein Lehrbuch für Studierende und Aerzte. 1990;6th edition 1 et 2[Google Scholar]

8. Kraepelin E. Psychiatrie. 8 Auflage Leipzig, Austria: Barth; 1909. English translation and adaptation by Barclay RM, Robertson GM. Dementia Praecox and Paraphrenia. Huntington, NY: Krieger Publishing; 1919 Reprinted 1971.[Google Scholar]

9. Berrios GE, Hauser R. The early development of Kraepelin's ideas on classification: a conceptual history. . Psychol Med. 1988;12:813–821. [PubMed] [Google Scholar]

10. Kraepelin E. Die Erscheinungsformen des Irreseins. Zeitschrift für die gesammte Neurologie und Psychiatrie. 1920;62:1–29. English translation by Marshall H. Patterns of mental disorder. In: Hirsch SR, Shepherd M, eds. Themes and Variations in European Psychiatry: an Anthology. Bristol, UK: John Wright & Sons; 1974:7-30..[Google Scholar]

11. Jackson J Hughlings. Remarks on evolution and dissolution of the nervous system. . J Ment Sci. 1887;33:25–48.[Google Scholar]

12. Bleuler E. Berlin, Germany: Springer Verlag; 1920. English translation: Textbook of Psychiatry. New York, NY: Arno Press. (1920) Lehrbuch der Psychiatrie.1976[Google Scholar]

13. Kasanin J. The acute schizoaffective psychosis. . Am J Psychiatry. 1933;90:97–126.[Google Scholar]

14. Langfeld G. The prognosis of schizophrenia. . Acta Psychiatr Neurol Scand. 1956;(suppl 110)[Google Scholar]

15. Stephens JH, Astrup C. Prognosis in “process” and “non-process” schizophrenia. . Am J Psychiatry. 1963;119:945–953.[Google Scholar]

16. Tsuang MT, Winokur G. Criteria for subtyping schizophrenia. . Arch Gen Psychiatry. 1974;31:43–47. [PubMed] [Google Scholar]

17. Schneider K. 8th edition,. 1950. Stuttgart, Germany: Thieme; 1950. English translation by Hamilton MW, Anderson EW. Clinical Psychopathology. New York, NY: Grune and Stratton; Klinische Psychopathologie, 1959[Google Scholar]

18. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria, Rationale and reliability. Arch Gen Psychiatry. 1978;35:773–782. [PubMed] [Google Scholar]

19. American Psychiatric Association. 3rd ed. Washington, DC: American Psychiatric Association; . Diagnostic and Statistical Manual of Mental Disorders. 1980[Google Scholar]

20. World Health Organization. Geneva, Switzerland: World Health Organization; The ICD-10 Classification of Mental and Behavioral Disorders. Clinical descriptions and diagnostic guidelines. 1992[Google Scholar]

21. Wing JK, Cooper JE, Sartorius N. London, UK: Cambridge University Press; Measurement and Classification of Psychiatric Symptoms. An Instruction Manual for the PSE and CATEGO Program. 1974[Google Scholar]

22. Cardno AG, Sham PC, Farmer AE, Murray RM, McGuffin P. Heritability of Schneider's first-rank symptoms . Br J Psychiatry. 2002;180:35–38. [PubMed] [Google Scholar]

23. Waters FAV, Badcock JC, Dragovic M, Jablensky A. Neuropsychological functioning in schizophrenia patients with first-rank (passivity) symptoms . Psychopathology. 2009;42:47–58. [PubMed] [Google Scholar]

24. Leonhard K. 2nd ed. Vienna, Austria; New York, NY: Springer; . Classification of Endogenous Psychoses and their Differentiated Etiology. 1999[Google Scholar]

25. Kallman FJ. New York, NY: Augustin; . The Genetics of Schizophrenia. 1938[Google Scholar]

26. Kendler KS, Gruenberg AM. An independent analysis of the Danish Adoption Study of Schizophrenia. VI. The relationship between psychiatric disorders as defined by DSM-III in the relatives and adoptees . Arch Gen Psychiatry. 1984;41:555–564. [PubMed] [Google Scholar]

27. Baron M, Risch N. The spectrum concept of schizophrenia: evidence for a genetic-environmental continuum . J Psychiatr Res. 1987;21:257–267. [PubMed] [Google Scholar]

28. Rado S. Theory and therapy: the theory of schizotypal organization and its application to the treatment of decompensated schizotypal behaviour. In: Scher SC, Davis HR, eds. . New York, NY: Grune and Stratton; . The Outpatient Treatment of Schizophrenia. 1960[Google Scholar]

29. Meehl PE. Schizotaxia, schizotypy, schizophrenia/ American Psychologist 1962;17: 827-838 Reprinted in Meehl PE . Minneapolis, MN: University of Minnesota Press; . Psychodiagnosis: Selected Papers.1973:135–155.[Google Scholar]

30. Chapman LJ, Chapman JP. Scales for rating psychotic and psychoticlike experiences as continua. . Schizophr Bull. 1980;6:476–489. [PubMed] [Google Scholar]

31. Kety SS, Wender PH, Jacobsen B, Ingraham LJ, Jansson L, Faber B. Mental illness in the biological and adoptive relatives of schizophrenic adoptees. . Arch Gen Psychiatry. 1994;51:442–455. [PubMed] [Google Scholar]

32. Kendler KS, Neale MC, Walsh D. Evaluating the spectrum concept of schizophrenia in the Roscommon Family Study. . Am J Psychiatry. 1995;152:749–754. [PubMed] [Google Scholar]

33. Fosatti A, Maffei C, Battaglia M, Bagnato M, Donati D, Donini M, et al. Latent class analysis of DSM-IV schizotypal personality disorder criteria in psychiatric patients. . Schizophr Bull. 2001;27:59–71. [PubMed] [Google Scholar]

34. Suhr JA, Spitznagel MB. Factor versus cluster models of schizotypal traits. I. A comparison of unselected and highly schizotypal samples . Schizophr Res. 2001;52:231–239. [PubMed] [Google Scholar]

35. Torgersen S, Onstad S, Skre I, Edvardsen J, Kringlen E. “True” schizotypal personality disorder: a study of co-twins and relatives of schizophrenic probands . Am J Psychiatry. 1993;150:1661–1667. [PubMed] [Google Scholar]

36. Strauss JS, Carpenter WT Jr, Bartko JJ. The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs . Schizophr Bull. 1974;XX:61–69. [PubMed] [Google Scholar]

37. Crow TJ. Molecular pathology of schizophrenia: more than one disease process? . BMJ. 1980;280:66–68.[PMC free article] [PubMed] [Google Scholar]

38. Andreasen NC, Olsen S. Negative v positive schizophrenia. Definition and validation . Arch Gen Psychiatry. 1982;39:789–794. [PubMed] [Google Scholar]

39. Crow TJ. The two-syndrome concept: origins and current status . Schizophr Bull. 1985;11:471–486. [PubMed] [Google Scholar]

40. Carpenter WT Jr, Heinrichs DW, Wagman AMI. Deficit and non-deficit forms of schizophrenia: the concept . Am J Psychiatry. 1988;145:578–583. [PubMed] [Google Scholar]

41. Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT Jr. Case identification and stability of the deficit syndrome of schizophrenia . Psychiatry Res. 1993;47:47–56. [PubMed] [Google Scholar]

42. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr. A separate disease within the syndrome of schizophrenia . Arch Gen Psychiatry. 2001;58:165–171. [PubMed] [Google Scholar]

43. Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT Jr. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. . Arch Gen Psychiatry. 1994;51:804–811. [PubMed] [Google Scholar]

44. Nkam I, Thibaut F, Denise P, Van Der Elst A, Ségard L, Brazo P, et al. Saccadic and smooth-pursuit eye movements in deficit and non-deficit schizophrenia. . Schizophr Res. 2001;48:145–153. [PubMed] [Google Scholar]

45. Arango C, Kirkpatrick B, Buchanan RW. Neurological signs and the heterogeneity of schizophrenia. . Am J Psychiatry. 2000;157:560–565. [PubMed] [Google Scholar]

46. Galderisi S, Maj M, Mucci A, et al. Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study . Am J Psychiatry. 2002;159:983–990. [PubMed] [Google Scholar]

47. Liddle PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. . Br J Psychiatry. 1987;151:145–151. [PubMed] [Google Scholar]

48. Johnstone EC, Frith CD. Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients . Psychol Med. 1996;26:669–679. [PubMed] [Google Scholar]

49. Smith DA, Mar CM, Turoff BK. The structure of schizophrenic symptoms: a meta-analytic confirmatory factor analysis . Schizophr Res. 1998;31:57–70. [PubMed] [Google Scholar]

50. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. . Arch Gen Psychiatry. 1995;52:352–360. [PubMed] [Google Scholar]

51. Gureje O, Aderibigbe YA, Obikoya O. Three syndromes in schizophrenia: validity in young patients with recent onset of illness . Psychol Med. 1995;25:715–725. [PubMed] [Google Scholar]

52. Emsley RA, Niehaus DJH, Mbanga NI, et al. The factor structure for positive and negative symptoms in South African Xhosa patients with schizophrenia. . Schizophr Res. 2001;47:149–157. [PubMed] [Google Scholar]

53. McGrath JA, Nestadt G, Liang KY, et al. Five latent factors underlying schizophrenia: analysis and relationship to illnesses in relatives . Schizophr Bull. 2004;30:855–873. [PubMed] [Google Scholar]

54. Cuesta MJ, Peralta V. Integrating psychopathological dimensions in functional psychoses: a hierarchical approach . Schizophr Res. 2001;52:215–229. [PubMed] [Google Scholar]

55. Farmer AE, McGuffin P, Spitznagel EL. Heterogeneity in schizophrenia: acluster-analytic approach. Psychiatry Res. 1983;8:1–12. [PubMed] [Google Scholar]

56. Dollfus S, Everitt B, Ribeyre JM, Assouly-Besse F, Sharp C, Petit M. Identifying subtypes of schizophrenia by cluster analyses . Schizophr Bull. 1996;22:545–555. [PubMed] [Google Scholar]

57. Sham PC, Castle DJ, Wessely S, Farmer AE, Murray RM. Further exploration of a latent class typology of schizophrenia . Schizophr Res. 1996;20:105–115. [PubMed] [Google Scholar]

58. Kendler KS, Karkowski LM, Walsh D. The structure of psychosis. Latent class analysis of probands from the Roscommon Family Study . Arch Gen Psychiatry. 1998;55:492–499. [PubMed] [Google Scholar]

59. Murray V, McKee I, Miller PM, et al. Dimensions and classes of psychosis in a population cohort: a four-class, four-dimension model of schizophrenia and affective psychoses . Psychol Med. 2005;35:499–510. [PubMed] [Google Scholar]

60. Woodbury MA, Clive J, Garson A. Mathematical typology: a Grade of Membership technique for obtaining disease definition . Comput Biomed Res. 1978;11:277–298. [PubMed] [Google Scholar]

61. Manton KG, Woodbury MA, Tolley DH. New York, NY: John Wiley; . Statistical Applications Using Fuzzy Sets. 1994[Google Scholar]

62. Manton KG, Korten A, Woodbury MA, Anker M, Jablensky A. Symptom profiles of psychiatric disorders based on graded disease classes: an illustration using data from the WHO International Pilot Study of Schizophrenia . Psychol Med. 1994;24:133–144. [PubMed] [Google Scholar]

63. Lewis SW, Reveley AM, Reveley MA, Chitkara B, Murray RM. The familial/sporadic distinction as a strategy in schizophrenia research . Br J Psychiatry. 1987;151:306–313. [PubMed] [Google Scholar]

64. Lyons MJ, Kremen WS, Tsuang MT. Faraone SV Investigating putative genetic and environmental forms of schizophrenia: methods and findings . Int Rev Psychiatr. 1989;1:259–276.[Google Scholar]

65. Roy M-A, Crowe RR. Validity of the familial and sporadic subtypes of schizophrenia . Am J Psychiatry. 1994;151:805–814. [PubMed] [Google Scholar]

66. O'Callaghan E, Larkin C, Kinsella A, Waddington JL. Obstetric complications, the putative familial-sporadic distinction, and tardive dyskinesia in schizophrenia . Br J Psychiatry. 1990;157:578–584. [PubMed] [Google Scholar]

67. Gottesman II, Bertelsen A. Confirming unexpressed genotypes for schizophrenia. Risks in the offspring of Fischer's Danish identical and fraternal discordant twins . Arch Gen Psychiatry. 1989;46:867–872. [PubMed] [Google Scholar]

68. Compton WM, Guze SB. The neo-Kraepelinian revolution in psychiatric diagnosis. . Eur Arch Psychiatry Clin Neurosci. 1995;245:196–201. [PubMed] [Google Scholar]

69. Feighner JP, Robins E, Guze SB, Woodruff RA Jr, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research . Arch Gen Psychiatry. 1972;26:57–63. [PubMed] [Google Scholar]

70. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Rationale and reliability . Arch Gen Psychiatry. 1978;35:773–782. [PubMed] [Google Scholar]

71. American Psychiatric Association . 4th edition. Washington DC: American Psychiatric Association; Diagnostic and Statistical Manual of Mental Disorders. 1994[Google Scholar]

72. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses . Am J Psychiatry. 2003;160:4–12. [PubMed] [Google Scholar]

73. Kerlinger FN. 2nd ed. London, UK: Holt, Rinehart & Winston; Foundations of Behavioural Research. 1973[Google Scholar]

74. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia . Am J Psychiatry. 1970;126:983–987. [PubMed] [Google Scholar]

75. Kendler KS. The nosologic validity of paranoia (simple delusional disorder): a review. Arch Gen Psychiatry . 1980;152:699–706. [PubMed] [Google Scholar]

76. Andreasen NC. The validation of psychiatric diagnosis: new models and approaches (editorial). . Am J Psychiatry. 1995;152:161–162. [PubMed] [Google Scholar]

77. Sneath PHA. Some thoughts on bacterial classification . J Gen Microbiol. 1957;17:84–200. [PubMed] [Google Scholar]

78. Swillen A, Vogels A, Devriendt K, Fryns JP. Chromosome 22q11 syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications . Am J Med Genet. 2000;97:128–135. [PubMed] [Google Scholar]

79. Ousley O, Rockers K, Dell ML, et al. A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: Implications for clinical evaluation and treatment . Curr Psychiatry Rep. 2007;9:148–158. [PubMed] [Google Scholar]

80. Carpenter WT, Bustillo JR, Thaker GK, Van Os J, Krueger RF, Green MJ. The psychoses: Cluster 3 of the proposed meta-structure for DSM-V and ICD-11 . Psychol Med. 2009;39:2025–2042. [PubMed] [Google Scholar]

81. Hempel CG. Englewood Cliffs, NJ: Prentice-Hall; . Philosophy of Natural Science. 1966[Google Scholar]

82. Millon T. Classification in psychopathology: rationale, alternatives, and standards . J Abnorm Psychol. 1991;100:245–261. [PubMed] [Google Scholar]

83. Grayson DA. Can categorical and dimensional views of psychiatric illness be distingushed? . Br J Psychiatry. 1987;26:57–63. [PubMed] [Google Scholar]

84. Skinner HA. Construct validation approach to psychiatric classification. In Millon T, Klerman GL, eds . New York, NY: Guilford Press; . Contemporary Directions in Psychopathology. 1986:307–330.[Google Scholar]

85. Ginsburg BE, Werick TM, Escobar JI, Kugelmass S, Treanor JJ, Wendtland L. Molecular genetics of psychopathologies: a search for simple answers to complex problems . Behav Genet. 1996;26:325–333. [PubMed] [Google Scholar]

86. Gottesman II, Shields J. Genetic theorizing and schizophrenia . Br J Psychiatry. 1973;122:15–30. [PubMed] [Google Scholar]

87. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. . Am J Psychiatry. 2003;160:636–645. [PubMed] [Google Scholar]

88. Almasy L, Blangero J. Endophenotypes as quantitative risk factors for psychiatric disease: rationale and study design . Am J Med Genet Neuropsychiatr Genet. 2001;105:42–44. [PubMed] [Google Scholar]

89. Goldberg TE, David A, Gold JM. Neurocognitive deficits in schizophrenia. In: Hirsch SR, Weinberger DR, eds . Cambridge MA: Blackwell Publishing; . Schizophrenia. 1993:168–184.[Google Scholar]

90. Heinrichs RW. The primacy of cognition in schizophrenia . Am Psychol. 2005;60:229–242. [PubMed] [Google Scholar]

91. Kremen WS, Buka SL, Seidman LJ, Goldstein JM, Koren D, Tsuang MT. IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study . Am J Psychiatry. 1998;155:672–677. [PubMed] [Google Scholar]

92. Mohamed S, Paulsen JS, O'Leary D, Arndt S, Andreasen N. Generalized cognitive deficits in schizophrenia. A study of first-episode patients. . Arch Gen Psychiatry. 1999;56:749–754. [PubMed] [Google Scholar]

93. Brewer WJ, Francey SM, Wood SJ, et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop firstepisode psychosis. . Am J Psychiatry. 2005;162:71–78. [PubMed] [Google Scholar]

94. Torrey EF. Studies of individuals never treated with antipsychotic medications: a review . Schizophr Res. 2002;58:101–115. [PubMed] [Google Scholar]

95. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV. Stability and course of neuropsychological deficits in schizophrenia . Arch Gen Psychiatry. 2001;58:24–32. [PubMed] [Google Scholar]

96. Kurtz MM. Neurocognitive impairment across the lifespan in schizophrenia: an update . Schizophr Res. 2005;74:15–26. [PubMed] [Google Scholar]

97. Heinrichs RW, Ruttan L, Zakzanis KK, Case D. Parsing schizophrenia with neurocognitive tests: evidence of stability and validity . Brain Cogn. 1997;35:207–224. [PubMed] [Google Scholar]

98. Kelly C, Sharkey V, Morrison G, Allardyce J, McCreadie RG. Nithsdale Schizophrenia Surveys 20// Cognitive function in a catchment-area-based population of patients with schizophrenia . Br J Psychiatry. 2000;177:348–353. [PubMed] [Google Scholar]

99. Rempfer MV, Hamera EK, Brown CE, Cromwell RL. The relations between cognition and the independent living skill of shopping in people with schizophrenia . Psychiatry Res. 2003;117:103–112. [PubMed] [Google Scholar]

100. Revheim N, Schecter I, Kim D, et al. Neurocognitive and symptom correlates of daily problem-solving skills in schizophrenia . Schizophr Res. 2006;283:237–245. [PubMed]

Sours: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181977/
Young Man on Being Diagnosed With Psychosis

History of schizophrenia

The word schizophrenia was coined by the Swiss psychiatrist and eugenicistEugen Bleuler in 1908, and was intended to describe the separation of function between personality, thinking, memory, and perception. He introduced the term on 24 April 1908 in a lecture given at a psychiatric conference in Berlin and in a publication that same year.[1][2] Bleuler later expanded his new disease concept into a monograph in 1911, which was finally translated into English in 1950.[3][4]

According to some, the disease has always existed only to be ‘discovered’ during the early 20th century. The plausibility of this claim depends upon the success of retrospectively diagnosing earlier cases of madness as ‘schizophrenia’. According to others, ‘schizophrenia’ names a culturally determined clustering of mental symptoms.[5] What is known for sure is that by the turn of the 20th century the old concept of insanity had become fragmented into ‘diseases’ (psychoses)[6] such as paranoia, dementia praecox, manic-depressive insanity and epilepsy (Emil Kraepelin’s classification).[7] Dementia praecox was reconstituted as schizophrenia, paranoia was renamed as delusional disorder and manic-depressive insanity as bipolar disorder (epilepsy was transferred from psychiatry to neurology). The ‘mental symptoms’ included under the concept schizophrenia are real enough, make people suffer, and will always need understanding and treatment. However, whether the historical construct currently called ‘schizophrenia’ is required to achieve this therapeutic goal remains contentious.

Diagnoses in ancient times[edit]

Accounts of a schizophrenia-like syndrome are thought to be rare in the historical record prior to the 19th century, although reports of irrational, unintelligible, or uncontrolled behavior were common.[8] There has been an interpretation that brief notes in the Ancient Egyptian Ebers papyrus may imply schizophrenia,[9] but other reviews have not suggested any connection.[10] A review of ancient Greek and Roman literature indicated that although psychosis was described, there was no account of a condition meeting the criteria for schizophrenia.[11]

Bizarre psychotic beliefs and behaviors similar to some of the symptoms of schizophrenia were reported in Arabic medical and psychological literature during the Middle Ages. In The Canon of Medicine, for example, Avicenna described a condition somewhat resembling the symptoms of schizophrenia which he called Junun Mufrit (severe madness), which he distinguished from other forms of madness (Junun) such as mania, rabies and manic depressive psychosis.[12] However, no condition resembling schizophrenia was reported in Şerafeddin Sabuncuoğlu's Imperial Surgery, a major Ottoman medical textbook of the 15th century.[13] Given limited historical evidence, schizophrenia (as prevalent as it is today) may be a modern phenomenon, or alternatively it may have been obscured in historical writings by related concepts such as melancholia or mania.[8]

Conceptual development[edit]

Influential earlier concepts[edit]

Main article: Dementia praecox

A detailed case report in 1809 by John Haslam concerning James Tilly Matthews,[14] and a separate account by Philippe Pinel also published in 1809, are often regarded as the earliest cases of schizophrenia in the medical and psychiatric literature.[8] The Latinized term dementia praecox entered psychiatry in 1886 in a textbook by asylum physician Heinrich Schüle (1840-1916) of the Illenau asylum in Baden. He used the term to refer to hereditarily predisposed individuals who were "wrecked on the cliffs of puberty" and developed acute dementia, while others developed the chronic condition of hebephrenia. Emil Kraepelin had cited Schüle's 1886 textbook in the 1887 second edition of his own textbook, Psychiatrie, and hence was familiar with this term at least six years before he himself adopted it.[15][16] It later appeared in 1891 in a case report by Arnold Pick which argued that hebephrenia should be regarded as a form of dementia praecox. Kraepelin first used the term in 1893. In 1899 Emil Kraepelin introduced a broad new distinction in the classification of mental disorders between dementia praecox and mood disorder (termed manic depression and including both unipolar and bipolar depression). Kraepelin believed that dementia praecox was caused by a lifelong, smoldering systemic or "whole body" process of a metabolic nature that would eventually affect the functioning of the brain in a final decisive cascade. Hence, he believed the entire body—all the organs, glands and peripheral nervous system—was implicated in the natural disease process.[17] Although he used the term "dementia," Kraepelin seemed to use the term synonymously with "mental weakness," mental defect," and "mental deterioration," but distinguished it from other uses of the term dementia, such as in Alzheimer's disease, which typically occur later in life.[18] In 1853 Bénédict Morel used the term démence précoce (precocious or early dementia) to describe a group of young patients who were suffering from "stupor".[19] It is sometimes argued that this first use of the term signals the medical discovery of schizophrenia. However, Morel employed the phrase in a purely descriptive sense and he did not intend to delineate a new diagnostic category. Moreover, his traditional conception of dementia differed significantly from that employed in the latter half of the nineteenth-century. Finally, there is no evidence that Morel's démence précoce had any influence on the later development of the dementia praecox concept by either Arnold Pick or Emil Kraepelin.[5]

Kraepelin's classification slowly gained acceptance. There were objections to the use of the term "dementia" despite cases of recovery, and some defence of diagnoses it replaced such as adolescent insanity.[20] The concept of adolescent insanity or developmental insanity had been advanced by Scottish psychiatrist Sir Thomas Clouston in 1873, describing a psychotic condition which generally afflicted those aged 18–24 years, particularly males, and in 30% of cases proceeded to ‘a secondary dementia’.[21]

Coinage in 1908[edit]

The word schizophrenia—which translates roughly as "splitting of the mind" and comes from the Greek roots schizein (σχίζειν, "to split") and phrēn, phren- (φρήν, φρεν-, "mind")[22]—was coined by Eugen Bleuler in 1908 and was intended to describe the separation of function between personality, thinking, memory, and perception. Bleuler described the main symptoms as four A's: flattened Affect, Autism, impaired Association of ideas and Ambivalence.[23] Bleuler realized that the illness was not a dementia as some of his patients improved rather than deteriorated and hence proposed the term schizophrenia instead. However, many at the time did not accept that splitting or dissociation was an appropriate description, and the term would later have more significance as a source of confusion and social stigma than scientific meaning.[24]

In popular culture, the term schizophrenia is often thought to mean that affected persons have a "split personality". But for contemporary psychiatry, schizophrenia does not involve a person changing among distinct multiple personalities. The stigmatising confusion arises in part due to Bleuler's own use of the term schizophrenia, which for many signalled a split mind, and his documenting of a number of cases with split personalities within his classic 1911 description of schizophrenia. The earliest known use of the term to mean "split personality" was by psychologist G. Stanley Hall in 1916, and many early 20th-century psychiatrists and psychologists can also be found using the term in this sense (some reference Jekyll and Hyde) before a later rejection of this usage took place.[25]

First-rank symptoms[edit]

In the early 20th century, the psychiatrist Kurt Schneider listed the forms of psychotic symptoms that he thought distinguished schizophrenia from other psychotic disorders. He termed these as first-rank symptoms. They include delusions of being controlled by an external force; the belief that thoughts are being inserted into or withdrawn from one's conscious mind; the belief that one's thoughts are being broadcast to other people; and hearing hallucinatory voices that comment on one's thoughts or actions or that have a conversation with other hallucinated voices.[26] Although they have significantly contributed to the current diagnostic criteria, the specificity of first-rank symptoms has been questioned. A review of the diagnostic studies conducted between 1970 and 2005 found that they allow neither a reconfirmation nor a rejection of Schneider's claims, and suggested that first-rank symptoms should be de-emphasized in future revisions of diagnostic systems.[27]

State abuses in the 20th century[edit]


In the first half of the 20th century schizophrenia was considered to be a hereditary defect, and sufferers were subject to eugenics in many countries. Hundreds of thousands were sterilized, with or without consent—the majority in Nazi Germany, the United States, and Scandinavian countries.[28][29] Along with other people labeled "mentally unfit", many diagnosed with schizophrenia were murdered in the Nazi "Action T4" program.[30]

Schizophrenia under Nazi rule[edit]

In 1933 Dr. Ernest Rüdin, who was in-charge of the Genealogical-Demographic Department of the German Institute for Psychiatric Research in Munich, expressed his interest in schizophrenia and with the help of Feanz Kallmann, supported the idea that schizophrenia was a Mendelian inherited disease. Kallmann believed that the disorder was transmitted by a regressive gene.[31]

Both Rüdin's and Kallmann’s theories coincided with the growing interest in the idea of Rassenhygiene or “race hygiene”. The eugenics movement had gained great strength in the United States and Britain. Following suit, in 1933 Rüdin became a guiding force in the passage of Germany’s first compulsory sterilization laws known as “the law for the prevention of progeny with hereditary defects” which would target individuals with mental retardation, schizophrenia, manic-depressive disorder, epilepsy, Huntington chorea, hereditary blindness and deafness, hereditary alcoholism and “grave bodily malformation.” It is suggested by the limited data available that of the 400,000 (1% of the entire population) that were sterilized, 132 000 were sterilized for schizophrenia.[32]

According to E. Fuller Toddy and Robert H. Yolken, it was in 1939 that Hitler asked his private physician and his officials to draft a law that would allow the systematic killing of individuals with mental disorders, sticking to a claim that he had made shortly after assuming office in 1933: “it is right that the worthless lives of such creatures should be ended, and that this would result in certain savings in terms of hospitals, doctors and nursing staff.” In 1932 Berthold Kihn had estimated that mentally ill patients were costing Germany 150 million Reichsmarks per year.[32]

In October 1939, German psychiatric hospitals were asked to carry out a survey which established that 70,000 patients would qualify for the goal of the program which was known as Aktion (action) T–4. The patients were killed with the use of carbon monoxide which they were given in a closed “shower” room. According to Friedlander, the “overriding criterion” for selection for death in the T–4 program “was the ability to do productive work”[33] useful by doing work such as dentistry or by pretending to be “asylum director”. Psychiatric asylums implemented two diets: minimum calories for those who could work and a starvation diet of vegetables only for those who could not.

Bruce Levine quotes the reaction of the superintendent of the Virginia Hospital from 1934 in regards to the sterilization of these populations by the Nazis, an indication to the reaction that was formed abroad: “The Germans are beating us at our own game".[34][better source needed]

Politicization in the Soviet Union[edit]

In the Soviet Union the diagnosis of schizophrenia has also been used for political purposes. The prominent Soviet psychiatrist Andrei Snezhnevsky created and promoted an additional sub-classification of sluggishly progressing schizophrenia. This diagnosis was used to discredit and expeditiously imprison political dissidents while dispensing with a potentially embarrassing trial.[35] The practice was exposed to Westerners by a number of Soviet dissidents, and in 1977 the World Psychiatric Association condemned the Soviet practice at the Sixth World Congress of Psychiatry.[36] Rather than defending his claim that a latent form of schizophrenia caused dissidents to oppose the regime, Snezhnevsky broke all contact with the West in 1980 by resigning his honorary positions abroad.[37]

Development of treatments in the 20th century[edit]

Harry Stack Sullivan applied the approaches of Interpersonal psychotherapy to treating schizophrenia in the 1920s viewing early schizophrenia as a problem-solving attempt to integrate life experiences, arguing that recovered patients were made more competent after a psychotic experience than before.[38]: 76 

In the early 1930s insulin coma therapy was trialed to treat schizophrenia but faded out of use in the 1960s following the advent of antipsychotics.[citation needed]

Antipsychotics were introduced to US hospitals in 1950s, following the discovery of chlorpromazine in 1952 and its trialing in French hospitals. Adoption was encouraged by advertising by the Smith, Kline & French company after it received permission to advertise use of the drug in 1954. Advertised under the brand name Thorazine, more than 2 million people had received the drug within 8 months. In the first report on chloropromazine's use in the US, John Vernon Kinross-Wright suggested that the drug could be used as an adjunct to psychotherapy to improve its effectiveness. [39]: 33–35 

By the 1960s adverts started to imply that antipsychotics explicitly addressed the causes of psychosis using terms like "psychocorrective." The 1973 text book, "The Companion to Psychiatric Studies" asserted that antipsychotics 'a specific therapeutic effect in schizophrenia, and that the term “tranquiliser” is a misnomer’ using the term anti-schizophrenic, discussing the dopamine hypothesis and by 1975 adverts asserted that drugs had an antipsychotic action through acting on dopamine receptors. [39]: 54–55 

Criticism of mainstream psychiatry[edit]


Anti-psychiatry refers to a diverse collection of thoughts and thinkers that challenge the medical concept of schizophrenia. Anti-psychiatry emphasizes the social context of mental illness and re-frames the diagnosis of schizophrenia as a labeling of deviance. Anti-psychiatry represented dissension of psychiatrists themselves about the understanding of schizophrenia in their own field.[40] Prominent psychiatrists in this movement include R. D. Laing, David Cooper. Related criticisms of psychiatry were launched by philosophers such as Michel Foucault, Jacques Lacan, Gilles Deleuze, Thomas Szasz, and Félix Guattari.[41]

Anti-psychiatrists agree that 'schizophrenia' represents a problem, and that many human beings have problems living in modern society. But they protest the notion that schizophrenia is a disease, and that people who suffer from it are sick. Instead, they often suggest that schizophrenics appear crazy because they are intelligent and sensitive beings confronted with a mad world. The sane patient can choose to go against medical advice, but the insane usually cannot. Anti-psychiatry often describes the institutional world as itself pathological and insane because of the way it subordinates human beings to bureaucracy, protocol, and labels.[40]

R. D. Laing[edit]

In his book, The Divided Self, published in 1960, R. D. Laing proposed a psychodynamic model of schizophrenia using the concept of ontological security. He presented a model where schizophrenia is the attempt of the "self", the attention of the mind, to escape the experiences of the world, the "body". The understanding and connection of others, he argued, is felt as either an attack or "smothering understanding" while simultaneously being longed for. Laing posited that in this state the "self" could become angry, hateful, and split and that the strange language of metaphor present in schizophrenia was simultaneously at attempt to avoid being understood, and to be partially understood, or to test a conversation partner. This position was supported by quotations from those diagnosed with schizophrenia. Laing stated that true understanding of the self can resolve schizophrenia.[42]: 137 

Evolution of diagnostic approaches[edit]

Controversies over validity in the 1970s[edit]

In 1970 psychiatrists Robins and Guze introduced new criteria for deciding on the validity of a diagnostic category[43] and proposed that cases of schizophrenia where people recovered well were not really schizophrenia but a separate condition.[44]

In the early 1970s, the diagnostic criteria for schizophrenia was the subject of a number of controversies which eventually led to the operational criteria used today. It became clear after the 1971 US-UK Diagnostic Study that schizophrenia was diagnosed to a far greater extent in America than in Europe.[45] This was partly due to looser diagnostic criteria in the US, which used the DSM-II manual, contrasting with Europe and its ICD-9. David Rosenhan's 1972 study, published in the journal Science under the title "On being sane in insane places", concluded that the diagnosis of schizophrenia in the US was often subjective and unreliable.[46]

DSM-III (1980) and DSM-IV (1994)[edit]

The 1970s controversies led to the revision not only of the diagnosis of schizophrenia, but the revision of the whole DSM manual, resulting in the publication of the DSM-III in 1980.[47] The revision was based on Feighner Criteria and Research Diagnostic Criteria that had in turn developed from Robins's and Guze's criteria, and which were intended to make diagnosis more reliable (consistent). Since the 1970s more than 40 diagnostic criteria for schizophrenia have been proposed and evaluated.[48]

The DSM-IV of 1994 showed an increased focus on an evidence-based medical model, with the diagnostic criteria for schizophrenia slightly adjusted to require one month of positive symptoms instead of one week.[49]

21st century[edit]

Subtypes of schizophrenia are no longer recognized as separate conditions from schizophrenia by DSM-5[50] or ICD-11.[51] Before 2013, the subtypes of schizophrenia were classified as paranoid, disorganized, catatonic, undifferentiated, and residual type.[52] The subtypes of schizophrenia were eliminated because of a lack of clear distinction among the subtypes and low validity of classification.[51][53]

See also[edit]


  1. ^Bleuler, Eugen (1908). "Die Prognose der Dementia Praecox -- Schizophreniegruppe". Allgemeine Zeitschrift für Psychiatrie. 65: 436–464.
  2. ^Cutting, John and Shepherd, Michael (1987). The Clinical Roots of the Schizophrenia concept: Translations of Seminal European Contributions to Schizophrenia. Cambridge: Cambridge University Press. pp. 59–74.
  3. ^Bleuler, Eugen (1911). Dementia Praecox oder Gruppe der Schizophrenien. Leipzig: Franz Deuticke.
  4. ^Bleuler, Eugen (1950). "Dementia Praecox or the Group of Schizophrenias". Vertex (Buenos Aires, Argentina). New York: International Universities Press. 21 (93): 394–400. PMID 21218204.
  5. ^ abBerrios G.E.; Luque R; Villagran J (2003). "Schizophrenia: a conceptual history". International Journal of Psychology and Psychological Therapy. 3: 111–140.
  6. ^Berrios G E (1987). "Historical Aspects of the Psychoses: 19th Century Issues". British Medical Bulletin. 43 (3): 484–498. doi:10.1093/oxfordjournals.bmb.a072197. PMID 3322481.
  7. ^Berrios GE, Hauser R (1988). "The early development of Kraepelin's ideas on classification. a conceptual history". Psychological Medicine. 18 (4): 813–821. doi:10.1017/S0033291700009740. PMID 3078049.
  8. ^ abcHeinrichs RW (2003). "Historical origins of schizophrenia: two early madmen and their illness". J Hist Behav Sci. 39 (4): 349–63. doi:10.1002/jhbs.10152. PMID 14601041.
  9. ^Okasha, A; Okasha, T (2000). "Notes on mental disorders in Pharaonic Egypt". History of Psychiatry. 11 (44): 413–424. doi:10.1177/0957154X0001104406. S2CID 71686504. Archived from the original on 2008-12-06.
  10. ^Nasser M (December 1987). "Psychiatry in Ancient Egypt"(PDF). Psychiatric Bulletin. 11 (12): 420–422. doi:10.1192/pb.11.12.420.
  11. ^Evans K, McGrath J, Milns R (May 2003). "Searching for schizophrenia in ancient Greek and Roman literature: a systematic review". Acta Psychiatrica Scandinavica. 107 (5): 323–30. doi:10.1034/j.1600-0447.2003.00053.x. PMID 12752027. S2CID 10370638. Archived from the original on 2012-12-09.
  12. ^Youssef HA, Youssef FA, Dening TR (March 1996). "Evidence for the existence of schizophrenia in medieval Islamic society". History of Psychiatry. 7 (25): 55–62. doi:10.1177/0957154X9600702503. PMID 11609215. S2CID 44459712.
  13. ^Higgins ES, Kose S (July 2007). "Absence of schizophrenia in a 15th-century Islamic medical textbook". Am J Psychiatry. 164 (7): 1120, author reply 1120–1. doi:10.1176/appi.ajp.164.7.1120. PMID 17606667.
  14. ^Carpenter, PK (July 1989). "Descriptions of schizophrenia in the psychiatry of Georgian Britain: John Haslam and James Tilly Matthews". Comprehensive Psychiatry. 30 (4): 332–8. doi:10.1016/0010-440x(89)90058-8. PMID 2667883.
  15. ^Noll, Richard (2011). American Madness: The Rise and Fall of Dementia Praecox. Cambridge, MA: Harvard University Press. pp. 63–64.
  16. ^Noll, Richard (2012). "Dementia praecox, 1886: A new turning point?". History of Psychiatry. 23 (2): 255–256. doi:10.1177/0957154x11428420. S2CID 143443153.
  17. ^Noll, Richard. "Whole Body Madness". Psychiatric Times (26 September 2012). Retrieved 26 September 2012.
  18. ^Hansen RA, Atchison B (2000). Conditions in occupational therapy: effect on occupational performance. Hagerstown, MD: Lippincott Williams & Wilkins. ISBN .
  19. ^Dowbiggin, Ian (1996), "Back to the future: Valentin Magnan, French Psychiatry, and The Classification of Mental Diseases, 1885-1925", Social History of Medicine, 9 (3): 383–408, doi:10.1093/shm/9.3.383, PMID 11618728
  20. ^McConaghey JC (1905). "Adolescent Insanity: A Protest against the Use of the Term "Dementia Præcox"". Journal of Mental Science. 51 (213): 340–348. doi:10.1192/bjp.51.213.340.
  21. ^O'Connell P, Woodruff PW, Wright I, Jones P, Murray RM (February 1997). "Developmental insanity or dementia praecox: was the wrong concept adopted?". Schizophr. Res. 23 (2): 97–106. doi:10.1016/S0920-9964(96)00110-7. PMID 9061806. S2CID 6781094.
  22. ^Kuhn R (2004). tr. Cahn CH. "Eugen Bleuler's concepts of psychopathology". Hist Psychiatry. 15 (3): 361–6. doi:10.1177/0957154X04044603. PMID 15386868. S2CID 5317716.
  23. ^Stotz-Ingenlath G (2000). "Epistemological aspects of Eugen Bleuler's conception of schizophrenia in 1911"(PDF). Medicine, Health Care and Philosophy. 3 (2): 153–9. doi:10.1023/A:1009919309015. PMID 11079343. S2CID 25457004. Retrieved 2008-07-03.
  24. ^Kim, Yoshiharu; Berrios, German E. (2001). "Impact of the term Schizophrenia on the culture of ideograph: The Japanese experience". Schizophrenia Bulletin. 27 (2): 181–185. doi:10.1093/oxfordjournals.schbul.a006864. PMID 11354585.
  25. ^McNally, Kieran (2016). A Critical History of Schizophrenia. London: Palgrave MacMillan.
  26. ^Schneider, K (1959). Clinical Psychopathology (5 ed.). New York: Grune & Stratton.
  27. ^Nordgaard J, Arnfred SM, Handest P, Parnas J (January 2008). "The diagnostic status of first-rank symptoms". Schizophrenia Bulletin. 34 (1): 137–54. doi:10.1093/schbul/sbm044. PMC 2632385. PMID 17562695.CS1 maint: multiple names: authors list (link)
  28. ^Allen GE (1997). "The social and economic origins of genetic determinism: a case history of the American Eugenics Movement, 1900–1940 and its lessons for today"(PDF). Genetica. 99 (2–3): 77–88. doi:10.1007/BF02259511. PMID 9463076. S2CID 20689824. Retrieved 2008-07-03.
  29. ^Bentall RP, Read JE, Mosher LR (2004). Models of Madness: Psychological, Social and Biological Approaches to Schizophrenia. Philadelphia: Brunner-Routledge. ISBN .
  30. ^Lifton, Robert Jay (1986). The Nazi doctors: medical killing and the psychology of genocide. New York: Basic Books. ISBN .
  31. ^Torrey, E. Fuller, and Robert H. Yolken. “Psychiatric Genocide: Nazi Attempts to Eradicate Schizophrenia | Schizophrenia Bulletin | Oxford Academic.” OUP Academic, Oxford University Press, 16 Sept. 2009, academic.oup.com/schizophreniabulletin/article/36/1/26/1868974.
  32. ^ abBurleigh M. Death and Deliverance: ‘Euthanasia’ in Germany c. 1900–1945. Cambridge: Cambridge University Press; 1994.
  33. ^Friedlander H. The Origins of Nazi Genocide. Chapel Hill, NC: University of North Carolina Press; 1995
  34. ^"Killing "Schizophrenics": Contemporary U.S. Psychiatry Versus Nazi Psychiatry". CounterPunch.org. 1 February 2017.
  35. ^Wilkinson G (1986). "Political dissent and "sluggish" schizophrenia in the Soviet Union". Br Med J (Clin Res Ed). 293 (6548): 641–2. doi:10.1136/bmj.293.6548.641. PMC 1341504. PMID 3092963.
  36. ^"Behavior: Censuring The Soviets". USA: TIME. 12 September 1977. Archived from the original on December 15, 2008.
  37. ^Levine S (May 1981). "The Special Committee on the Political Abuse of Psychiatry". Psychiatr. Bull. 5 (5): 94–95. doi:10.1192/pb.5.5.94.
  38. ^Bloom, Samuel William; Bloom, Samuel W. (2002). The Word as Scalpel: A History of Medical Sociology. Oxford University Press. ISBN .
  39. ^ abJ. Moncrieff (15 September 2013). The Bitterest Pills: The Troubling Story of Antipsychotic Drugs. Springer. ISBN .
  40. ^ abCrossley, Nick (1 October 1998). "R. D. Laing and the British anti-psychiatry movement: a socio–historical analysis". Social Science & Medicine. 47 (7): 877–889. doi:10.1016/S0277-9536(98)00147-6. PMID 9722108.
  41. ^Hebdige, Dick (1996). "Chapter 8: Postmodernism and the 'other side'". In David Morley (ed.). Stuart Hall: Critical Dialogues in Cultural Studies. Psychology Press. ISBN .
  42. ^R. D. Laing (28 January 2010). The Divided Self: An Existential Study in Sanity and Madness. Penguin Books Limited. ISBN .
  43. ^Kendell, R; Jablensky, A (2003). "Distinguishing between the validity and utility of psychiatric diagnoses". The American Journal of Psychiatry. 160 (1): 4–12. doi:10.1176/appi.ajp.160.1.4. PMID 12505793. S2CID 16151623.
  44. ^Robins E, Guze SB (January 1970). "Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia". Am J Psychiatry. 126 (7): 983–7. doi:10.1176/ajp.126.7.983. PMID 5409569.
  45. ^Wing JK (January 1971). "International comparisons in the study of the functional psychoses". British Medical Bulletin. 27 (1): 77–81. doi:10.1093/oxfordjournals.bmb.a070819. PMID 4926366.
  46. ^Rosenhan D (1973). "On being sane in insane places". Science. 179 (4070): 250–8. Bibcode:1973Sci...179..250R. doi:10.1126/science.179.4070.250. PMID 4683124. S2CID 146772269.
  47. ^Wilson M (March 1993). "DSM-III and the transformation of American psychiatry: a history". American Journal of Psychiatry. 150 (3): 399–410. doi:10.1176/ajp.150.3.399. PMID 8434655.
  48. ^Jansson LB, Parnas J (September 2007). "Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?". Schizophr Bull. 33 (5): 1178–200. doi:10.1093/schbul/sbl065. PMC 3304082. PMID 17158508.
  49. ^Fischer BA (December 2012). "A review of American psychiatry through its diagnoses: the history and development of the Diagnostic and Statistical Manual of Mental Disorders". The Journal of Nervous and Mental Disease. 200 (12): 1022–30. doi:10.1097/NMD.0b013e318275cf19. PMID 23197117. S2CID 41939669.
  50. ^"Schizophrenia". University of Michigan Department of Psychiatry. Archived from the original on 2013-04-03. Retrieved 2013-06-24.
  51. ^ abReed GM, First MB, Kogan CS, et al. (February 2019). "Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders". World Psychiatry. 18 (1): 3–19. doi:10.1002/wps.20611. PMC 6313247. PMID 30600616.
  52. ^"Updates to DSM-5 Criteria & Text". www.psychiatry.org. Retrieved 2019-02-21.
  53. ^Tandon, Rajiv (2014). "Schizophrenia and Other Psychotic Disorders in Diagnostic and Statistical Manual of Mental Disorders (DSM)-5: Clinical Implications of Revisions from DSM-IV". Indian Journal of Psychological Medicine. 36 (3): 223–225. doi:10.4103/0253-7176.135365. ISSN 0253-7176. PMC 4100404. PMID 25035542.
Sours: https://en.wikipedia.org/wiki/History_of_schizophrenia

Similar news:

Sometimes I win. Sometimes I lose. Lost this year, and here I am Christie's slave.

3868 3869 3870 3871 3872